2026 International Congress of Diabetes and Metabolism(2일차)

세부 일정 (95강)

• 08:00~08:15 Evaluating and comparing CGM accuracy and reliability: insights from recent clinical trial Room 4 김지윤(성균관의대 내과)
• 08:00~08:15 Managing residual atherogenic dyslipidemia in patients with type 2 diabetes Room 5 허지혜(한림의대 내과)
• 08:15~08:30 Personalized diabetes management enabled by CGM and digital health solutions Room 4 이준엽(가톨릭의대 내과)
• 08:15~08:30 Ideal combination therapy for T2DM: SGLT-2i & TZD Room 5 배재현(한림의대 내과)
• 08:30~09:00 휴식 ( )
• 09:00~09:25 Semaglutide and the new era of metabolic medicine: mechanisms, evidence, and future directions Room 1 Daniel J. Drucker(University of Toronto)
• 09:25~09:50 Beyond the threat : achieving total metabolic and cardiovascular success with once-weekly semaglutide Room 1 Darren McGuire(University of Texas Southwestern Medical Center)
• 09:50~10:15 Navigating the real-world patient journey: efficacy and tolerability of once-weekly semaglutide Room 1 Ryo Suzuki(Tokyo Medical University)
• 09:00~09:25 GPR40 (FFAR1) as a therapeutic target in type 2 diabetes: mechanistic insights and clinical potential Room 2 이용호(연세의대 내과)
• 09:25~09:50 Targeting intestinal and renal glucose transport: the rationale and clinical implications of SGLT1/2 dual inhibitors Room 2 이은영(가톨릭의대 내과)
• 09:50~10:15 Novel therapeutics for muscle health: in the context of obesity and more Room 2 전해민(한미약품)
• 09:00~09:20 New insights into the molecular events that lead to MASLD. Room 3 Jay D. Horton(UT Southwestern School of Medicine USA)
• 09:20~09:40 Metabolic–epigenomic coupling determines adipose plasticity and metabolic health Room 3 Juro Sakai(Tohoku University Japan)
• 09:40~10:00 Targeting autophagy in infection and inflammation Room 3 조은경(충남의대)
• 10:00~10:20 Panel discussion Room 3 이재민 임승순 정창화(DGIST 계명대학교 의과대학 한국식품연구원)
• 09:00~09:25 Genetic architecture and heterogeneity in type 1 diabetes: from GWAS to functional insights Room 4 Stephen S. Rich(University of Virginia)
• 09:25~09:50 Heterogeneity of diabetes in East Asians Room 4 Wayne H-H Sheu(National Health Research Institutes Taiwan)
• 09:50~10:15 Genomic and multi-omic insights into the heterogeneity of diabetic kidney disease Room 4 배재현(서울의대 내과)
• 09:00~09:20 Practical screening and emotional coaching for diabetes distress Room 5 나영(여의도성모병원 간호팀)
• 09:20~09:40 Nutritional strategies: reducing diet-related distress Room 5 임현정(경희대학교 의학영양과)
• 09:40~10:00 Psychosocial interventions for diabetes distress: addressing psychosocial and environmental determinants Room 5 이지현(강남세브란스병원 사회사업팀)
• 10:00~10:20 Panel discussion Room 5 김원준 장연정 김동철(울산의대 내과 세브란스병원 간호팀 인하대학교병원 당뇨비만센터)
• 09:00~09:20 Gestational diabetes as a window into life-course diabetes risk Room 6 곽수헌(서울의대 내과)
• 09:20~09:40 Youth-onset diabetes in Korea: epidemiology and a national registry for prevention and care Room 6 김재현(서울의대 소아청소년과)
• 09:40~10:00 Toward optimal diabetes care in Korean older adults through evidence-based management strategies Room 6 윤재승(가톨릭의대 내과)
• 10:00~10:20 Panel discussion Room 6 임주현 문준호 김지윤 정한나(국립보건연구원 서울의대 내과 성균관의대 내과 한림의대 내과)
• 10:20~10:30 휴식 ( )
• 10:30~10:40 Opening address ( )
• 10:40~11:20 Mitigating the consequences of hyperglycaemia in type 2 diabetes: lessons from the UKPDS Room 1 Rury R. Holman(University of Oxford UK)
• 11:20~12:00 Answered prayers: the GLP-1 RA related medications provide efficacy beyond appetite and incretin effects Room 1 Donna Ryan(Pennington Biomedical Research Center USA)
• 12:00~12:10 휴식 ( )
• 12:10~12:25 The role of DPP-4 inhibitors in Korean diabetes care: focusing on k-evidence Room 2 이용호(연세의대 내과)
• 12:10~12:25 T2D management in the CKM Era: the role of combination therapy in glycemic control Room 3 김수경(경상의대 내과)
• 12:10~12:25 Does switching within the DPP-4 inhibitor class make a real difference?: integrating Korean RWE into diabetes care Room 4 이지은(차의과학대 내과)
• 12:10~12:25 Re-evaluation of glucose lowering effect in DPP4i Room 5 이은영(가톨릭의대 내과)
• 12:25~12:40 Importance of timely insulin initiation: optimizing glycemic control with 2nd generation basal insulin following GLP-1 RA treatment Room 2 오태정(서울의대 내과)
• 12:25~12:40 One pill, broader benefits: the early T2D journey Room 3 김혜경(연세의대 내과)
• 12:25~12:40 Beyond weight loss; advancing obesity management through efpeglenatide Room 4 임수(서울의대 내과)
• 12:25~12:40 Management of inadequately controlled patients with diabetes mellitus Room 5 최덕현(순천향의대 내과)
• 12:40~13:40 점심식사 ( )
• 13:40~14:05 Restoring reproductive health: unexpected effects of incretin-based therapy on fertility and reproductive function Room 1 Mojca Jensterle(University Medical Centre Ljubljana Slovenia)
• 14:05~14:30 Rewiring reward pathways: the impact of NUSH-based therapy on addiction and compulsive behaviors Room 1 민세희(울산의대 내과)
• 14:30~14:55 Beyond type 2 diabetes: emerging roles of NUSH-based therapy in type 1 diabetes Room 1 Viral N Shah(Indiana University USA)
• 13:40~14:00 Overview of key revisions and the Korean evidence initiative Room 2 배재현(서울의대 내과)
• 14:00~14:20 Updating the T2D algorithm: weight-centric and CKM-oriented approaches Room 2 김진화(조선의대 내과)
• 14:20~14:40 Next-generation therapies for T2D with obesity Room 2 오태정(서울의대 내과)
• 14:40~15:00 Expanding CGM indications and digital health integration Room 2 문선준(성균관의대 내과)
• 13:40~14:00 Regulated necrosis in diabetes: ferroptosis in β-cell failure and complications Room 3 고관표(제주의대 내과)
• 14:00~14:20 Redox protein modification controls plasma membrane lipid peroxidation during ferroptosis Room 3 이은우(KRIBB)
• 14:20~14:40 Lysosomal lipid peroxidation triggers ferroptosis induction Room 3 Ken-ichi Yamada(Kyushu University)
• 14:40~15:00 Panel discussion Room 3 이윤희 이헌상 정수명(서울대 약대 고려대학교 생명과학부 성균관대학교 생명과학부)
• 13:40~14:05 The metabolic landscape of cancer prognosis: an epidemiologic perspective Room 4 Sixten Harborg(Aarhus University Denmark)
• 14:05~14:30 Hyperinsulinemia, inflammation, and cancer: mechanisms Room 4 최연경(경북의대 내과)
• 14:30~14:55 Impact of anti-diabetic agents on cancer risk: focusing on GLP-1 RA and SGLT2i Room 4 정창희(울산의대 내과)
• 13:40~14:00 Strategies to expand patient enrollment and strengthen the home healthcare pilot program Room 5 곽효선 (대구가톨릭대학병원)
• 14:00~14:20 Analyzing dropout factors and improving adherence in the home healthcare pilot program Room 5 최영진 (강동경희대병원)
• 14:20~14:40 Pancreatic disability registration: patient benefits, registration process, and real-world challenges Room 5 구민정(서울대학교병원)
• 14:40~15:00 Panel discussion Room 5 진혜경 이혜미 김민경(단국대학교병원 삼성서울병원 서울아산병원)
• 13:40~13:55 Understanding class effect and clinical variability in SGLT2 inhibition Room 6 손장원(가톨릭의대 내과)
• 13:55~14:10 SGLT2 Inhibition in Asian populations (Indonesia) Room 6 Soebagijo Adi Soelistijo(RSUD Dr. Soetomo Indonesia)
• 14:10~14:25 Exploring a next-generation approach in SGLT2 inhibition based on Asian clinical evidence Room 6 서다혜(인하의대 내과)
• 14:25~14:40 Panel discussion Room 6 Nanny N.M. Soetedjo 전숙 서성환(Universitas Padjadjaran Indonesia 경희의대 내과 성균관의대 내과)
• 13:40~13:50 Metabolic dysfunction-associated steatotic liver disease and all-cause and cause-specific mortality Room 7 오로사(성균관의대 내과)
• 13:50~14:00 Use of glucagon-like peptide-1 receptor agonists does not increase the risk of cancer in patients with type 2 diabetes mellitus Room 7 김미진(부산의대 내과)
• 14:00~14:10 Prevalence, incidence, and metabolic characteristics of young adults with type 2 diabetes mellitus in South Korea (2010–2020) Room 7 김지윤(성균관의대 내과)
• 14:10~14:20 Macrophage-specific progranulin deficiency prevents diet-induced obesity through the inhibition of hypothalamic and adipose tissue inflammation Room 7 박채범(울산의대 내과)
• 14:20~14:30 Ultra-processed food intake and risk of type 2 diabetes mellitus: a dose-response meta-analysis of prospective studies Room 7 김유진(고려대 보건정책학과)
• 14:30~14:40 Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis Room 7 Wenqi Fan(The Second Xiangya Hospital of Central South University China)
• 14:40~16:00 휴식 ( )
• 15:10~15:50 Cellular senescence, diabetes, and complications of metabolic disease: the potential roles of senotherapies Room 1 James L. Kirkland(Cedars-Sinai Medical Center USA)
• 15:50~16:00 휴식 ( )
• 16:00~16:25 Expanding spectrum of complication of diabetes based on CKM concept Room 1 임수(서울의대 내과)
• 16:25~16:50 Interplay between MASLD and diabetes Room 1 Norbert Stefan(University Tübingen Germany)
• 16:50~17:15 Diabetes and cognitive decline: focusing on neurodegeneration Room 1 김희진(한양의대 신경과)
• 16:00~16:40 Year in review and perspectives in the field of diabetes: clinical Room 2 이은정(성균관의대 내과)
• 16:40~17:20 From mechanisms to medicines: key discoveries in diabetes research 2026 Room 2 고은희(울산의대 내과)
• 16:00~16:20 CGM coverage and real-world uptake patterns in Korea: a national registry analysis Room 3 김재현(성균관의대 내과)
• 16:20~16:40 CGM standards and policy integration Room 3 Sof Andrikopoulos(Australian Diabetes Society Australia)
• 16:40~16:55 Clinical implementation of CGM-linked lifestyle self-monitoring device Room 3 이다영(고려의대 내과)
• 16:55~17:10 Beyond glucose: AI transforming diabetes complications Room 3 Gaurav Puri(Metro South Health Australia)
• 17:10~17:20 Panel discussion Room 3 유승현 서지아(가톨릭관동의대 내과 고려의대 내과)
• 16:00~16:20 Comparative analysis of DPN screening and diagnostic protocols across Asian guidelines: addressing resource-limited settings Room 4 Bin Lu(Fudan University)
• 16:20~16:40 Defining the Asian phenotype: distinct clinical and pathogenetic characteristics of DPN in diverse Asian populations Room 4 진흥용(전북의대 내과)
• 16:40~17:00 Regional variations in pharmacological management of painful DPN: a review of first-line agents and access to novel therapies Room 4 Rayaz A Malik(Hamad Medical Center)
• 17:00~17:20 Panel discussion Room 4 오태정 윤지희 강선미(서울의대 내과 화순전남대학교병원 순천향의대 내과)
• 16:00~16:25 Chrono-DM: the temporal dimension of prediabetes—linking sleep profiles, chronotype, and glycaemic control in Malaysian adults Room 5 Satvinder Kaur(UCSI University Kuala Lumpur Malaysia)
• 16:25~16:50 AI-driven digital health platform for personalized nutrition: from CGM data to actionable insights Room 5 김산(대상웰라이프)
• 16:50~17:15 Tailored nutritional intervention: practical application of CGM-based glycemic data Room 5 송윤주(가톨릭대학교 식품영양학과)
• 16:00~16:25 The emerging role of nsMRA in CKM care Room 6 Hiddo Lambers Heerspink(University Medical Center Groningen)
• 16:25~16:50 Scientific overview and clinical implication of Asian patients with finerenone Room 6 Daiji Kawanami(Fukuoka University)
• 16:50~17:15 Bridging evidence and real world experience for cardio-renal protection Room 6 조윤경(울산의대 내과)
• 16:00~16:20 Global perspectives on reimbursement for advanced diabetes technology Room 7 김준환(카카오헬스)
• 16:20~16:40 Integrating diabetes technology into tertiary hospital evaluation: strategies for enhancing type 2 diabetes management quality Room 7 최덕현(순천향의대 내과)
• 16:40~17:00 Strategic revision of the general principles for antidiabetic medication reimbursement based on clinical practice guidelines Room 7 강아름(부산의대 내과)
• 17:00~17:20 Panel discussion Room 7 강준혁 이진한 박상준 이지현 김선영(보건복지부 보험약제과 동아일보 순천향의대 내과 아주대학교병원 삼성서울병원)